0001358403-19-000083.txt : 20190611
0001358403-19-000083.hdr.sgml : 20190611
20190611165855
ACCESSION NUMBER: 0001358403-19-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190611
FILED AS OF DATE: 20190611
DATE AS OF CHANGE: 20190611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ward Shane
CENTRAL INDEX KEY: 0001638380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 19891534
MAIL ADDRESS:
STREET 1: C/O VERSARTIS, INC.
STREET 2: 4200 BOHANNON DR., SUITE 250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_156028672027200.xml
FORM 4
X0306
4
2019-06-11
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001638380
Ward Shane
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Sr. VP and General Counsel
Stock Option (right to buy)
1.87
2019-06-11
4
A
0
45000
0
A
2029-06-10
Common Stock
45000.0
45000
D
25% of the shares subject to the stock option vest and become exercisable on January 1, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
/s/ Rosemary Y. Williams, Attorney-in-Fact
2019-06-11